@compliance4all is now active and back on X.
We’ll be delivering:
📌Quick, actionable updates across FDA, OSHA, ISO
📌Clear, practical threads on compliance & regulatory changes.
📌Regular updates on expert-led webinars from https://t.co/hWkzAfPHSb
Follow for timely insights and industry-relevant compliance guidance. Stay tuned for our first update!
✨ Quick Tip for Professionals:
Don’t wait for a crisis to review your compliance & safety policies. A 15-minute weekly check-in with your team can save you from hours of headaches (and $$ in penalties) later.
#Leadership#WorkplaceSafety#Compliance
🔍 Clinical trials are evolving.
ICH E6(R3) & FDA now demand smarter risk-based quality management—with sharper focus on patient safety & data integrity.
Join expert Charles H. Paul to learn how to:
✔️ Implement RBQM
✔️ Align with FDA expectations
✔️ Avoid compliance pitfalls
🔗 https://t.co/CYMTWcZYCd
#ClinicalTrials #FDA #RBQM #ICH #Pharma
⚡️Think a small 1099 mistake won’t hurt? Think again.
A mismatched name/TIN can trigger penalties, backup withholding, or even an IRS audit.
Get the latest 2025 updates on 1099 & W-9 compliance with expert Justin Muscolino .
🔗https://t.co/FSLvLBBr7t
#IRS #1099 #W9 #TaxCompliance #Accounting
🚨 OSHA shows up at your door.. What happens next? From injury reporting rules to handling compliance officer interviews, knowing how to prepare & respond can mean the difference between a smooth inspection & costly citations.
Learn from OSHA expert William Principe .
🔗https://t.co/kWyqXawP5K
3. Dynamic data shift: Regs now push real-world evidence over static claims; integrate post-market surveillance upfront to slash MLR review times.
What's a compliance surprise you've hit? Check our webinars at https://t.co/zfKQZtpup7 for more! #QualityAssurance"
FDA compliance pros: Here are 3 under-the-radar insights that could save you from 483s or delays. These hidden gems boost your QA/RA game without the basics. #FDA#PharmaCompliance#MedTech#GMP#RegulatoryAffairs"
2. SIUU comms: Firms can share unbiased off-label data with HCPs, but overlook the 'firm-initiated' vs. 'responsive' rule—mixing them risks enforcement.
✅Value: Train teams to respond reactively for safe education.
💊 A drug can be FDA-approved but still reach patients in a substandard state.
⚠️ Temperature swings.
⚠️ Supply chain lapses.
⚠️ Hidden risks.
30+ year pharma veteran Michael Esposito shares how to stop substandard meds before they harm patients or your brand.
🔗 https://t.co/zoyYCqIiIC
#Pharma #GMP #FDA #quality
Why do multi-million dollar IT projects fail?
👉 Subcontractors.
👉 Sponsors.
👉 Data conversion.
👉 Denial.
PM veteran Payson Hall has seen it all.
Learn 12 patterns of failure—before they sink your project.
🔗 https://t.co/w7XlP6a920
#PMO#CIO#EnterpriseIT
Your device evolves. The FDA asks: Is it still the same device? 🤔
Even minor changes in software, labeling, or materials can trigger the need for a new 510(k).
✅ Learn how to apply FDA’s guidance, spot the tipping point, and defend your decisions with confidence.
🎟️ Join John E. Lincoln (28+ yrs in FDA-regulated industry): https://t.co/nRTQI1jpZ0
#FDA #510k #MedicalDevices #RegulatoryAffairs #Compliance
If your SOPs are just “documents on SharePoint”… you’re already at risk.
Learn how to make SOPs that actually improve performance + keep you inspection-ready.
#Pharma#GMP#FDA#Compliance#SOP
📄 A poorly written SOP can:
❌ Confuse employees
❌ Cause training failures
❌ Trigger FDA warning letters
Yet most pharma SOPs still miss the mark. Here’s why it matters 🧵
This 4-hour virtual seminar with pharma documentation & GMP training expert Michael Esposito covers:
✅ How to write clear, compliant SOPs
✅ FDA/EMA expectations
✅ Tying SOPs directly to training & job performance
✅ Avoiding ambiguity that risks compliance
🔗 https://t.co/D8NC8Ms4Tt
If your org touches GxP data, you cannot afford to get validation wrong.
Learn how to stay compliant while modernizing with cloud & SaaS.
🎯 Register now (live or on-demand):
🔗 https://t.co/ihPAzEmV7z
#FDA #Compliance #Pharma #MedTech #SaaSMarketing
💡 Moving to Cloud, SaaS, or COTS?
🚨 One FDA audit could shut it all down if your system isn’t validated.
That’s why regulated industries must rethink their approach to software, cloud, and compliance. 🧵
In this live session with 35+ yrs FDA veteran , Carolyn Troiano, you’ll learn:
✅ Agile vs. Waterfall for SDLC & validation
✅ FDA’s CSV → CSA shift & what it means for you
✅ Validating SaaS, IaaS, PaaS & cloud vendors
✅ 21 CFR Part 11 + data integrity best practices
Charles H. Paul has spent 3 decades helping companies meet critical US & EU submission deadlines.
In this live session, he’ll teach you the scheduling methods top teams use to hit approvals on time.
📅 Live or on-demand: https://t.co/vMQx6S4TfL
#MedicalDevices #FDA #EUMDR #ProjectManagement
A $2M medical device launch was delayed 14 months because of one missed EU MDR deadline.
The company? Competitor got to market first.
The cause? Poor project scheduling.
Here’s how to make sure this never happens to you. 👇